Incentives added to support China’s rollout of centralized procurement

As China begins the nationwide rollout of its centralized procurement program for generics and off-patent originator drugs, the government has released additional guidelines that include incentives to encourage use of the drugs.

In September,

Read the full 341 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE